Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2018 3
2019 4
2020 7
2021 4
2022 7
2023 12
2024 8
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal effects of dimethyl fumarate on patient-reported outcome measures in multiple sclerosis: treatment satisfaction, quality of life, depressive symptoms, sleep, and work productivity.
Abolfazli R, Sahraian MA, Shaygannejad V, Ashtari F, Shahmohammadi S, Poursadeghfard M, Baghbanian SM, Majdinasab N, Nahayati MA, Hosseini S, Azarfam JY, Navardi S, Torabi HR, Ayromlou H, Saeidi M, Talebi M, Nikseresht A, Niknam Z, Azimi A, Sedighi B, Ghiasian M, Ghalyanchi-Langroodi H, Pourakbar E, Heidari H, Kamali H, Mohammadianinejad E, Ghaffari M, Mosarrezaii A, Bayati A, Yaseri M, Shali A, Samadzadeh S. Abolfazli R, et al. Among authors: ghiasian m. J Clin Neurosci. 2026 Apr;146:111877. doi: 10.1016/j.jocn.2026.111877. Epub 2026 Jan 28. J Clin Neurosci. 2026. PMID: 41610777 Clinical Trial.
Mortality After Cerebral Venous Thrombosis.
Häppölä E, Hiltunen S, Lindgren E, Kinnula V, Zuurbier SM, Heldner MR, Mansour M, Silvis S, Devasagayam S, Kleinig TJ, Ghiasian M, Barboza MA, Arauz A, Tatlisumak T, Yeşilot N, Arnao V, Ferro JM, De Sousa DA, Leker RR, Simaan NM, Garcia-Esperon C, Spratt NJ, Guisado-Alonso D, Arnold M, Jood K, Coutinho JM, Putaala J. Häppölä E, et al. Among authors: ghiasian m. Neurology. 2025 Oct 7;105(7):e213947. doi: 10.1212/WNL.0000000000213947. Epub 2025 Sep 2. Neurology. 2025. PMID: 40893114
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial.
Sahraian MA, Abolfazli R, Shaygannejad V, Ashtari F, Majdinasab N, Navardi S, Baghbanian SM, Sedighi B, Naser Moghadasi A, Nahayati MA, Ghalyanchi Langroodi H, Mohammadianinejad SE, Beladi Moghadam N, Ayromlou H, Nikseresht A, Ghiasian M, Razazian N, Asadollahzadeh E, Sabzvari A, Kafi H, Albooyeh S. Sahraian MA, et al. Among authors: ghiasian m. Sci Rep. 2024 Oct 22;14(1):24921. doi: 10.1038/s41598-024-75745-y. Sci Rep. 2024. PMID: 39438591 Free PMC article. Clinical Trial.
Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous Thrombosis.
Lindgren E, Shu L, Simaan N, Krzywicka K, de Winter MA, Sánchez van Kammen M, Molad J, Klein P, Hallevi H, Barnea R, Heldner MR, Hiltunen S, de Sousa DA, Ferro JM, Arauz A, Putaala J, Arnold M, Nguyen TN, Stretz C, Tatlisumak T, Jood K, Yaghi S, Leker RR, Coutinho JM; DIAS research collaboration; Mansour M, Canhão P, Ekizoglu E, Rodrigues M, Silva EM, Garcia-Esperon C, Arnao V, Aladin S, Mendel R, Aridon P, Sezgin M, Alasheev A, Smolkin A, Guisado-Alonso D, Yesilot N, Barboza MA, Ghiasian M, Silvis SM, Fang T, Siegler JE, Wu T, Wilson D, Asad SD, Al Kasab S, Almallouhi E, Frontera J, Rothstein A, Bakradze E, Omran SS, Henninger N, Kuohn L, Zubair A, Sharma R, Kerrigan D, Aziz Y, Mistry E, Zuurbier SM. Lindgren E, et al. Among authors: ghiasian m. JAMA Neurol. 2024 Dec 1;81(12):1274-1283. doi: 10.1001/jamaneurol.2024.3481. JAMA Neurol. 2024. PMID: 39432281 Free PMC article.
Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY).
Shaygannejad V, Ashtari F, Saeidi M, Beladi Moghadam N, Ghalyanchi Langroodi H, Baghbanian SM, Abolfazli R, Ghiasian M, Ayromlou H, Asadollahzadeh E, Sabzvari A, Kafi H, Azimi Saeen A. Shaygannejad V, et al. Among authors: ghiasian m. Mult Scler Relat Disord. 2024 Oct;90:105839. doi: 10.1016/j.msard.2024.105839. Epub 2024 Aug 20. Mult Scler Relat Disord. 2024. PMID: 39217809 Clinical Trial.
46 results